Original Research
Published on 27 Jun 2024
Delabelling beta-lactam allergy
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1423719
- 1,295 views
Type at least 3 characters
390 articles
Articles
Original Research
Published on 26 Jun 2024
Statin use and fall risk in adults: a cross-sectional survey and mendelian randomization analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1364733
- 2,284 views
- 1 citation
Original Research
Published on 24 Jun 2024
Pulmonary haemorrhage and haemoptysis associated with bevacizumab-related treatment regimens: a retrospective, pharmacovigilance study using the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1339505
- 1,106 views
- 1 citation
Original Research
Published on 20 Jun 2024
Effect of ultrashort-acting β-blockers on 28-day mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a meta-analysis of randomized controlled trials and trial sequential analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1380175
- 954 views
Original Research
Published on 20 Jun 2024
Consumer awareness and knowledge regarding use of non-steroidal anti-inflammatory drugs (NSAIDs) in a metropolitan area
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362632
- 1,480 views
Original Research
Published on 14 Jun 2024
Hepatitis-related adverse events associated with immune checkpoint inhibitors in cancer patients: an observational, retrospective, pharmacovigilance study using the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1383212
- 1,381 views
- 1 citation
Original Research
Published on 14 Jun 2024
Risk of immune system and skin and subcutaneous tissue related adverse events associated with oxaliplatin combined with immune checkpoint inhibitors: a pharmacovigilance study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1309540
- 904 views
Systematic Review
Published on 12 Jun 2024
An overview and single-arm meta-analysis of immune-mediated adverse events following COVID-19 vaccination
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1308768
- 1,269 views
Original Research
Published on 12 Jun 2024
The prevalence of polypharmacy and hyper-polypharmacy among middle-aged vs. older patients in Saudi Arabia: a cross-sectional study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1357171
- 1,606 views
- 3 citations
Original Research
Published on 12 Jun 2024
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403093
- 872 views
Original Research
Published on 07 Jun 2024
A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1397029
- 3,675 views
Data Report
Published on 06 Jun 2024
The last 3 decade of vaccination coverage in the Balkan and Eastern Europe countries with reference to the impact of the COVID-19 pandemic
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1278771
- 3,295 views
Original Research
Published on 05 Jun 2024
Comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events—a real-world longitudinal inception cohort study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1357567
- 931 views
Original Research
Published on 05 Jun 2024
Post-marketing safety of lorlatinib: a real-world study based on the FDA adverse event reporting system
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1385036
- 2,404 views
Original Research
Published on 31 May 2024
Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1370661
- 1,772 views
- 1 citation
Original Research
Published on 30 May 2024
A real-world pharmacovigilance analysis for transthyretin inhibitors: findings from the FDA adverse event reporting database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1368244
- 1,557 views
- 1 citation